Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Aphios Awarded United States Patent

Abstract:
Patent for Compositions and Methods for Inhibiting 5-Alpha Reductase

Aphios Awarded United States Patent

Woburn, MA | Posted on July 27th, 2010

Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-á Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (á) reductase enzyme.

5-á reductase is responsible for causing benign prostatic hyperplasia (BPH) and male pattern baldness (alopecia) in men as well as hirsutism (male-pattern body hair) in women. An estimated 50% of men above 50 in the United States have BPH that causes urinary hesitation and frequent urination and night time visits to the bathroom. The incidence of BPH increases to 60% for men over sixty, 70% for men above 70, 80% or men above 80 following an Arrhenius-type plot. BPH has been linked to the incidence of prostate cancer that is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US.

More than 500,000 prostate cancer cases are diagnosed each year in the United States, 1 in 6 American males will develop prostate cancer and 300,000 die of prostate cancer each year.

This invention is utilized in Aphios' SuperCool™ Palmetto and Sperol™ products for several conditions including benign prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other androgen hyperactivity diseases. The active pharmaceutical ingredient, finasteride, of Merck's Proscar® for BPH and Propecia® for male pattern baldness work by the same mechanism of 5-á reductase inhibition as SuperCool™ Palmetto and Sperol™, which are natural alternatives to these drugs with fewer side effects.

The source for the active pharmaceutical ingredients in both SuperCool™ Palmetto and Sperol™ is the Serenoa repens (Saw Palmetto) berry.

The therapeutic compositions of the invention were discovered using Aphios' patented SuperFluids™ CXF drug discovery technologies and manufactured using Aphios' patented SuperFluids™ CXP drug manufacturing technologies. These technologies ensure purity, increase extraction efficiency and overall yield, and are environmentally friendly. These technologies are also utilized in Aphios' Zindol® and SuperCool™ Gingerol products for nausea and vomiting, and Xantol™ and SuperCool™ St. John's products for emotional well-being, relaxed outlook, and positive moods.

Research leading to this invention was in part conducted under a SBIR grant 1R43 AT00321-01 from the National Center of Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH). The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of NCCAM and NIH.

####

About Aphios
Aphios®, www.aphios.com and www.SuperCoolHealth.com, is a “green” biotechnology company developing enabling technology platforms for improved drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Based on these platforms, we are developing enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders.

For more information, please click here

Contacts:
Trevor P. Castor, Ph.D.
CEO
781-932-6933

Copyright © Aphios

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanomedicine

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Announcements

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Patents/IP/Tech Transfer/Licensing

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016

Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016

NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016

Nanobiotechnology

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project